- ￥4800
- Tanda
- 美国
- TD-26210
- 2026年01月23日
- ELISA, WB, IHC
- Mouse
- 脊椎动物
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
A synthetic peptide from the internal region of PIK3CA which includes the mutation of E542Q, human origin.
- 亚型：
IgG
- 形态：
液体
- 保存条件：
-20℃
- 克隆性：
单克隆
- 标记物：
FITC
- 适应物种：
脊椎动物
- 保质期：
24个月
- 抗原来源：
蛋白
- 目录编号：
TD-26210
- 级别：
科研级
- 库存：
999
- 供应商：
武汉天德
- 宿主：
Mouse
- 应用范围：
ELISA, WB, IHC
- 浓度：
1mg/ml
- 靶点：
E542Q
- 抗体英文名：
Anti PIK3CA(E542Q) Mouse Monoclonal Antibody
- 抗体名：
PIK3CA(E542Q)
- 规格：
100μl
PIK3CA(E542Q)
| Cat. #: TD-26210 |
| Size: 100 µL |
| Gene Symbol: PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha |
| Description: Anti-PIK3CA(E542Q) Mouse Monoclonal Antibody |
| Background: Phosphatidyl 3-kinases (PI3K) are a family of lipid kinases involved in many cellular processes, including cell growth, proliferation, differentiation, motility, and survival. It is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit. Mutants of PIK3CA has been found in the pathogenesis of several cancers, including colon cancer, gliomas, gastric cancer, breast cancer, endometrial cancer, and lung cancer. |
| Immunogen: A synthetic peptide from the internal region of PIK3CA which includes the mutation of E542Q, human origin. |
| Applications: ELISA, WB, IHC |
| Recommended Dilutions: ELISA: 1:1000-1:5000 WB: 1:500-1:1000 IHC: 1:50-1:100 |
| Concentration: 1 mg/ml |
| Host Species: Mouse |
| Format: Liquid |
| Clonality: Monoclonal |
| Isotype: IgG |
| Purity: Purified from ascites |
| Preservative: No |
| Constituents: PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 50% glycerol |
| Species Reactivity: Recognizes E542Q mutant, but not wild type PIK3CA of vertebrates. |
| Storage Conditions: Store at -20°C. Avoid repeated freezing and thawing |
Western blot:
 |
Immunofluorescence:
 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验q-values PAFAH1B3 10.211 8.1924e-009 1.8315e-005 1.8315e-005 RAB31 -13.702 2.8016e-008 3.1316e-005 3.1316e-005 LRP1 -9.0742 1.6453e-007 0.00012261 5.3953e-005 KIAA0367 -8.9398 1.7404e-007 9.7272e-005 5.3953e-005 ID2B
cancers (4 -6 ) have already contributed to the identification of the putative oncogene PIK3CA (7 ).
Adv Sci∣周祥团队合作揭示通过工程化外泌体诱导肿瘤细胞核仁应激的分子机制与策略
研究员，南昌大学基础医学院陈加祥教授和南昌大学第一附属医院邓军主任医师为论文的共同通讯作者。复旦大学附属肿瘤医院甘雨博士、郝茜博士和新乡医学院健康中原研究院韩涛教授为论文共同第一作者。该工作还得到了宇玫博生物的大力支持。 文献原文： 【1】Gan Y, Hao Q, Han T, Tong J, Yan Q, Zhong H, Gao B, Li Y, Xuan Z, Li P, Yao L, Xu Y, Jiang YZ, Shao ZM, Deng J, Chen J, Zhou X
技术资料暂无技术资料 索取技术资料
